The 194 people with Parkinson’s disease involved in ... Researchers identify 21 existing drugs that could treat coronavirus Check out the Valentine Week List 2025, along with the Valentine ...

The US Food and Drug Administration (FDA) rejected three prior regulatory applications before granting approval.

AbbVie's growth thrives on strong earnings, a robust immunology portfolio, and diversification. See why ABBV stock is a ...

It’s not a secret that sleep can get more difficult with age — research suggests that up to half of older adults complain of sleep problems. That translates to some 27 million Americans over 65.

Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...

The following is a look at some of those who make up what is becoming an alarmingly long list of performers who are dealing with health issues: Iconic singer Michael Bolton’s recent announcement as he ...

Acadia Pharmaceuticals' forecasted revenues top $1bn in 2025. Find out why ACAD stock is a "Buy" with its profitable outlook ...

A violinist plays for her father. A singer takes requests. In hospitals and hospices, bedside performers offer a new kind of ...

“Any obesity is a big risk for high blood pressure but, again, abdominal fat is an especially big contributor,” says Chiesa. ...

The drug is intended for patients experiencing ... The approval adds Onapgo to a growing list of infusion-based Parkinson’s treatments. AbbVie’s Vyalev (foscarbidopa and foslevodopa ...

We recently published a list of 7 Best Nanotech Penny Stocks to Invest In. In this article, we are going to take a look at ...

In the second episode of The Deep End, listeners hear what it’s like to live with severe depression and the backstory of an experimental treatment.